OTeixeira

TL3 Regular · Grenoble, FR

Clinician. Posts general information only, and says so every time.

Joined 27 September 2024 · last posted 1d · groups: clinicians

139 posts, newest first. Showing up to 150.

Here for the analytics and not much else Replied, post #99 · Lounge › Introductions · 27 Jul 2026 · 27 likes Introductions are also a reasonable place to say what you are hoping to find, because somebody will usually know whether it exists here already. Anyone who has looked…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #96 · Compounds › Repair & healing peptides · 23 Jul 2026 · 1 like This follows post #95 rather than contradicting it. Adding what did not work for me on Stability of BPC-157, since the failures never get written up and they are half…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #84 · Compounds › Retatrutide · 22 Jul 2026 · 4 likes Reading this retatrutide discussion thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
I joined for one answer and stayed for a year — what changed my mind Replied, post #101 · Start Here › Welcome · 22 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
What to bring: records that a clinician can actually use — a second dataset Replied, post #64 · Clinical › Prescriber conversations · 22 Jul 2026 · 0 likes Taking post #61 at face value and following it one step further. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
Transit times by route, from a logged dataset Replied, post #26 · Sourcing › Logistics · 22 Jul 2026 · 0 likes Careful with the language on transit times. "Not detected" and "not present" are different findings and the first is a statement about the method.
Follow-up: How compounding permissions changed when supply normalised Replied, post #54 · Sourcing › Regulatory · 22 Jul 2026 · 1 like Reading back through the compounding permissions threads from last year, the same three questions come up every time and only one of them has ever been answered…
What published stability data actually covers, and what it does not Replied, post #12 · Practice › Storage & stability · 21 Jul 2026 · 23 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. A weak preference rather than a position.
What a reversed-phase purity number actually is Replied, post #70 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 3 likes Adding the measurement that post #67 says would settle it. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #13 · Clinical › Prescriber conversations · 18 Jul 2026 · 0 likes Post #12 is right about the mechanism and I think understates the practical bit. Bringing a record of symptoms with dates and severities makes an assessment materially…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #70 · Practice › Dosing & titration · 16 Jul 2026 · 11 likes Holding at a dose that is working is a legitimate position and it is not what the trial protocols did. The protocols escalated to a target because they were measuring…
Priming a pen and whether the primed volume is wasted Replied, post #6 · Devices › Pens & autoinjectors · 14 Jul 2026 · 10 likes Narrowing post #5, because the general version has more than one answer. A pen that will not dial to the intended dose is usually telling you the cartridge does not…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #124 · Practice › Reconstitution · 14 Jul 2026 · 12 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
Ultrasound and skinfolds: operator dependence in practice Replied, post #54 · Outcomes › Body composition · 12 Jul 2026 · 16 likes The failure mode on ultrasound and skinfolds is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple…
What I would want from a home test that does not exist yet — what changed since Replied, post #90 · Analytics › Home & field testing · 11 Jul 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
Revisiting: How this community labels and discusses unrefereed work Replied, post #21 · Evidence › Preprints · 11 Jul 2026 · 5 likes Useful. I had the fact and not the reason, which turns out to be the important half.
What steady state means for the decision to escalate Replied, post #23 · Practice › Dosing & titration · 3 Jul 2026 · 21 likes Adding the measurement that post #22 says would settle it. Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #72 · Sourcing › Red flags · 29 Jun 2026 · 0 likes Answering the question post #68 raises rather than the one it answers. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or…
Journal club: what we got wrong in an earlier session Replied, post #36 · Evidence › Journal club · 28 Jun 2026 · 0 likes The arithmetic in post #34 is right; the assumption feeding it is the part to check. The most common failure mode is spending fifty minutes on the effect size and ten…
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #11 · Nutrition & Training › Protein & intake · 28 Jun 2026 · 12 likes Post #9 and I disagree about the size of the effect, not about the direction. Published guidance on protein during weight loss is reasonably consistent and is easy to…
A fridge failure and how I assessed the contents afterwards Replied, post #15 · Devices › Cold chain · 25 Jun 2026 · 5 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. The honest summary: pack quality is visible, transit history is…
Electrolyte supplements: which ones do anything Replied, post #36 · Nutrition & Training › Hydration & electrolytes · 21 Jun 2026 · 17 likes Commercial rehydration formulations are designed for a specific purpose and are not equivalent to a sports drink, whatever the marketing suggests. Happy to be corrected…
Batch numbers that do not match the vial label Replied, post #29 · Sourcing › Red flags · 14 Jun 2026 · 9 likes On batch numbers, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Talking to a therapist about this specifically Replied, post #12 · Wellbeing › Mental health · 12 Jun 2026 · 1 like Post #9 answers the question as asked. The question underneath it is different. If you are in crisis, contact a local emergency or crisis service rather than posting. A…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #41 · Clinical › Bloodwork · 7 Jun 2026 · 28 likes Where the Liver enzymes drifting reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Tracking a shortage from primary sources rather than rumour Replied, post #37 · Access › Shortages · 5 Jun 2026 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
A pooled estimate that changed when one trial was added Replied, post #5 · Evidence › Meta-analyses · 1 Jun 2026 · 0 likes Worth separating two things that post #4 runs together. Practical note on pooled estimate: write down what you expect before you look. The number of times I have found…
Injection volume, overload, and peak distortion Replied, post #29 · Analytics › HPLC & UHPLC · 31 May 2026 · 10 likes A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table…
A site rotation scheme that is easy enough to actually follow Replied, post #71 · Practice › Administration · 24 May 2026 · 0 likes Where I part company with post #69, and it is a narrow parting. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #82 · Compounds › Tirzepatide · 23 May 2026 · 6 likes Weight reduction figures from SURMOUNT-1 are frequently quoted without the trial's duration attached. A mean change at 72 weeks and a mean change at 40 weeks are…
Prescription requirements and telehealth models — a second dataset Replied, post #38 · Sourcing › Regulatory · 22 May 2026 · 5 likes Filing a mild objection to the consensus on Prescription requirements and telehealth models. Mild because I might be wrong; an objection because nobody has addressed…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #10 · Clinical › Comorbidities · 20 May 2026 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
Revisiting: Patterns that reliably precede a problem, documented Replied, post #5 · Sourcing › Red flags · 19 May 2026 · 12 likes Post #4 is right about the mechanism and I think understates the practical bit. Patterns that reliably precede a problem: underdosing (less active material than stated,…
Revisiting: Absolute versus relative contraindications Replied, post #86 · Safety › Contraindications · 9 May 2026 · 6 likes Building on post #84 rather than restating it. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring…
The headache that turns out to be dehydration — the long version Replied, post #31 · Nutrition & Training › Hydration & electrolytes · 6 May 2026 · 23 likes Answering the question post #29 raises rather than the one it answers. Commercial rehydration formulations are designed for a specific purpose and are not equivalent to…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #27 · Analytics › COA interpretation · 2 May 2026 · 7 likes Answering the question post #25 raises rather than the one it answers. "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate…
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #18 · Pharmacology › Pharmacokinetics · 16 Apr 2026 · 31 likes Genuine question rather than a rhetorical one: has anyone here actually observed Half-life, as opposed to read about it? The thread is long and I cannot tell.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #30 · Meta › Announcements · 13 Apr 2026 · 8 likes Useful. I have added it to my own notes with the date on it.
Spike-and-recover accuracy for a peptide assay Replied, post #66 · Analytics › Method validation · 9 Apr 2026 · 0 likes Adding what did not work for me on spike-and-recover accuracy, since the failures never get written up and they are half the useful information.
Revisiting: Drawing up with one needle and injecting with another Replied, post #29 · Practice › Administration · 3 Apr 2026 · 1 like Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
Sample handling between despatch and injection Replied, post #14 · Analytics › Method validation · 2 Apr 2026 · 3 likes Worth separating two things that post #12 runs together. Linearity across the working range is a routine demonstration and it constrains how far a result can be…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #74 · Clinical › Bloodwork · 2 Apr 2026 · 24 likes I read post #72 twice before replying, because I had assumed the opposite. Practical answer on reference intervals, since the theoretical one is upthread: do the…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #88 · Pharmacology › Pharmacokinetics · 30 Mar 2026 · 3 likes Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none.
Run-in periods and the population they select Replied, post #89 · Evidence › Trials · 27 Mar 2026 · 0 likes This follows post #86 rather than contradicting it. Reframing run-in periods slightly, because I think the disagreement is about the question rather than the answer. If…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #108 · Clinical › Bloodwork · 22 Mar 2026 · 33 likes Post #107 is right about the mechanism and I think understates the practical bit. Lipid changes during substantial weight loss are expected and their trajectory is not…
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #8 · Practice › Side effects · 17 Mar 2026 · 3 likes Right — I had this wrong and I am glad to have read it before it mattered.
Grapefruit: why this class is not the class that cares Replied, post #33 · Practice › Interactions · 12 Mar 2026 · 0 likes Post #32 answers the question as asked. The question underneath it is different. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk…
Where impurities in solid-phase peptide synthesis come from Replied, post #49 · Analytics › Impurities & related substances · 11 Mar 2026 · 0 likes Everything in post #47 holds. The case it does not cover is the one I have. Summarising the impurities in solid-phase peptide synthesis thread so far, since it is long…
[2026 update] What a purity-only report leaves out Replied, post #49 · Sourcing › Independent verification · 10 Mar 2026 · 29 likes I changed my mind about purity-only after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way…
[2026 update] Composite endpoints and the component doing the work Replied, post #24 · Evidence › Trials · 8 Mar 2026 · 2 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Choosing which test to pay for, given a fixed budget Replied, post #16 · Sourcing › Independent verification · 7 Mar 2026 · 0 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #137 · Compounds › Semaglutide · 7 Mar 2026 · 3 likes Coming back to post #133, because the follow-up matters more than the original answer. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight…
Contributing data without breaching anyone's privacy Replied, post #61 · Data & Tools › Datasets · 6 Mar 2026 · 1 like Everything in post #57 holds. The case it does not cover is the one I have. Where a dataset is used to support a claim in a maintained document, the version used should…
The lowest dose that does anything: is that a real question? Replied, post #57 · Practice › Dosing & titration · 5 Mar 2026 · 4 likes Answering the question post #55 raises rather than the one it answers. Lowest dose: I would want to see the raw numbers rather than the summary before agreeing.…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #85 · Access › International · 1 Feb 2026 · 2 likes Same experience here, different supplier, so it is at least not unique to one of them.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #16 · Clinical › Special populations · 21 Jan 2026 · 11 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done.
Revisiting: Language barriers in accessing a prescription abroad Replied, post #66 · Access › International · 21 Jan 2026 · 26 likes Good question, well framed, and I would like to see it answered properly.
Gastro-oesophageal reflux: improving or worsening? Replied, post #8 · Clinical › Comorbidities · 31 Dec 2025 · 2 likes Gastro-oesophageal reflux looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Reverse causation in a cohort study of weight and outcome Replied, post #6 · Evidence › Study critique · 28 Dec 2025 · 23 likes Small methodological point on reverse causation: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Why a compound being unapproved is not the same as being illegal to possess Replied, post #44 · Sourcing › Regulatory · 26 Dec 2025 · 0 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. The interesting part of this is…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #78 · Compounds › Oral incretins · 25 Dec 2025 · 1 like Where I part company with post #77, and it is a narrow parting. The thirty-minute wait before eating is not conservatism. Food in the stomach materially reduces…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #15 · Compounds › Oral incretins · 22 Dec 2025 · 5 likes Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are near a trough rather than perturbing a slowly moving…
Publishing an inconvenient result: a case study — the long version Replied, post #73 · Sourcing › Independent verification · 17 Dec 2025 · 2 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
Tracking a preprint to publication: a worked example Replied, post #35 · Evidence › Preprints · 3 Dec 2025 · 12 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting.
A payment that went through twice: how it was resolved Replied, post #10 · Sourcing › Payments · 2 Dec 2025 · 0 likes Partial shipment with the balance to follow should be agreed in advance rather than discovered on arrival. Where it is agreed, it is unremarkable.
What a purity-only report leaves out Replied, post #97 · Sourcing › Independent verification · 21 Nov 2025 · 3 likes Coming back to post #93, because the follow-up matters more than the original answer. The most useful thing anyone has posted about purity-only in this category was a…
Tracking that stops updating and then resumes — the long version Replied, post #39 · Sourcing › Logistics · 16 Nov 2025 · 3 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. That is where I would start, not where I would stop.
History of disordered eating and why it changes the conversation Replied, post #22 · Clinical › Special populations · 13 Nov 2025 · 31 likes Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an individual assessment.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #36 · Compounds › Oral incretins · 9 Nov 2025 · 0 likes I had written a reply contradicting post #34 and deleted it. Here is what survived. Anyone comparing published oral and injectable efficacy should check whether the…
[2026 update] What steady state means for the decision to escalate Replied, post #16 · Practice › Dosing & titration · 6 Nov 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
Where to report an adverse event officially, by region — a second dataset Replied, post #80 · Safety › Adverse events · 1 Nov 2025 · 17 likes Post #77 is the version of this I will quote in future. One addition. Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #125 · Compounds › Tirzepatide · 24 Oct 2025 · 0 likes I had written a reply contradicting post #123 and deleted it. Here is what survived. One more thing on SURMOUNT-4 that took me far too long to see: the two figures…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #8 · Outcomes › Body composition · 23 Oct 2025 · 32 likes Building on post #7 rather than restating it. Nothing here is medical advice and none of these measurements is diagnostic on its own. I have said this before in a…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #16 · Clinical › Special populations · 20 Oct 2025 · 0 likes I think the older adults question is answerable and has not been answered, which is a more optimistic position than most of this thread.
How to read a forest plot, properly, from scratch Replied, post #43 · Evidence › Trials · 20 Oct 2025 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Revisiting: Power cut for eleven hours: how I assessed it afterwards Replied, post #5 · Practice › Storage & stability · 19 Oct 2025 · 0 likes Noted, and thank you for writing it out rather than summarising it.
Documentation that appears only after payment Replied, post #52 · Sourcing › Red flags · 18 Oct 2025 · 17 likes Where I part company with post #48, and it is a narrow parting. Nothing here should be read as an accusation against a named company, and the guidelines exist so that…
Follow-up: Why appetite effects are mostly central Replied, post #61 · Pharmacology › Receptor biology · 8 Oct 2025 · 5 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #112 · Evidence › Study critique · 16 Sep 2025 · 26 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not. I would not…
Managing an unplanned gap in supply — what changed since Replied, post #57 · Access › Shortages · 8 Sep 2025 · 5 likes Coming back to post #55, because the follow-up matters more than the original answer. Managing an unplanned gap is one of those subjects where the general answer and…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #31 · Analytics › Method validation · 4 Sep 2025 · 30 likes Whatever the answer on LOD and LOQ turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
MALDI versus ESI for a quick identity check Replied, post #3 · Analytics › Mass spectrometry · 2 Sep 2025 · 16 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Deconvoluted spectra are easier to read and hide the…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #116 · Practice › Reconstitution · 31 Aug 2025 · 3 likes Summarising the 10 mg vial reconstituted three thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #102 · Compounds › Secretagogues & GH axis · 26 Aug 2025 · 13 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #49 · Practice › Side effects · 23 Aug 2025 · 2 likes Smaller meals, less fat, slower eating and stopping earlier than feels natural are the interventions most consistently described as helping. None of them are drug…
Publishing an inconvenient result: a case study Replied, post #67 · Sourcing › Independent verification · 16 Aug 2025 · 15 likes Nobody has said the unglamorous part of publishing an inconvenient result yet, so: most of the variation is explained by things that are boring to write about and easy…
Which panel is worth repeating and which is worth ignoring Replied, post #80 · Clinical › Bloodwork · 9 Aug 2025 · 11 likes An update on my earlier panel post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Enforcement priorities versus written rules — does this still hold? Replied, post #2 · Sourcing › Regulatory · 7 Aug 2025 · 29 likes I disagree with the framing of Enforcement priorities above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can…
Are there stupid questions here? A staff answer, at length Replied, post #46 · Start Here › Welcome · 6 Aug 2025 · 17 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #49 · Evidence › Journal club · 6 Aug 2025 · 1 like STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #5 · marked as the solution · Start Here › How to Ask · 3 Aug 2025 · 7 likes Post #3 put the caveat in the right place and I want to underline it. Say what you have already ruled out. "It is not the diluent because I tried a second vial from a…
Travel coolers and how long they really hold Replied, post #27 · Devices › Cold chain · 2 Aug 2025 · 5 likes I would be cautious about generalising from the travel coolers example above. It is a good example. It is one example.
Travel coolers and how long they really hold Replied, post #16 · Devices › Cold chain · 1 Aug 2025 · 0 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
Substitution between formats during a shortage Replied, post #28 · Access › Shortages · 25 Jul 2025 · 25 likes Post #26 and I disagree about the size of the effect, not about the direction. Patient advocacy during shortages: some advocacy groups advocate for patients during…
Repeatability versus intermediate precision Replied, post #92 · Analytics › Method validation · 29 Jun 2025 · 8 likes On post #90 — agreed on the reasoning, with one qualification. I disagree with the framing of repeatability versus intermediate precision above, and I think it is a…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #54 · Evidence › Journal club · 26 Jun 2025 · 26 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #52 · Evidence › Trials · 13 Jun 2025 · 1 like Post #50 put the caveat in the right place and I want to underline it. Source for the Comparators chosen for regulatory reasons figure, since it was asked for. It is in…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #18 · Sourcing › Regulatory · 12 Jun 2025 · 0 likes Worth separating two things that post #14 runs together. Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a…
Storing a pen in use versus a pen unopened Replied, post #18 · Devices › Pens & autoinjectors · 4 Jun 2025 · 32 likes Disposal of a used pen is a sharps question even where the needle is retracted, and local rules vary more than people expect. That holds for the case as described.…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #126 · Compounds › Cagrilintide & amylin analogues · 1 Jun 2025 · 0 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
Coming back to: What published stability data actually covers, and what it does not Replied, post #44 · Practice › Storage & stability · 19 May 2025 · 5 likes Narrowing post #41, because the general version has more than one answer. The most useful thing anyone has posted about published stability data actually covers in this…
Coverage for the indication versus for the drug Replied, post #56 · Access › Insurance & coverage · 7 May 2025 · 4 likes The practical version of coverage is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Certificates issued by the seller versus by a laboratory Replied, post #59 · Analytics › COA interpretation · 24 Apr 2025 · 18 likes Certificates from a supplier's own laboratory are not independent by definition. That is not an accusation, it is a description, and it is why independent submission…
Follow-up: Requesting a page: what makes a good request Replied, post #19 · Documentation › Wiki requests · 8 Apr 2025 · 0 likes Say what would make the page wrong. A page whose failure conditions are stated is much easier to review honestly. The variance between people here is larger than the…
Coming back to: An 18-month record including the parts that went badly Replied, post #35 · Outcomes › Progress reports · 4 Apr 2025 · 0 likes Adding the boring version of 18-month record, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
Cost per milligram, computed honestly across formats — the long version Replied, post #52 · Access › Pricing · 2 Apr 2025 · 12 likes Independent testing is a real cost and belongs in the comparison. A cheaper supplier tested every lot may cost more in total. I have kept the units in throughout, for…
Counter-ion content and its effect on measured mass Replied, post #8 · Analytics › Mass spectrometry · 30 Mar 2025 · 0 likes Post #4 describes the usual case. This is about the unusual one. Offering a way to settle counter-ion content rather than another opinion about it. Two measurements,…
An emergency department visit, described afterwards Replied, post #6 · Safety › Adverse events · 25 Mar 2025 · 32 likes Attribution is genuinely hard for a single case and the reporting schemes are designed to work with that. You are not expected to prove causation to file. I am…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #29 · Compounds › Tirzepatide · 23 Mar 2025 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #8 · Evidence › Journal club · 10 Mar 2025 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I have kept…
What a 2 ppm match establishes, and what it does not Replied, post #4 · Analytics › Mass spectrometry · 6 Mar 2025 · 0 likes Post #2 describes the usual case. This is about the unusual one. Resolution and mass accuracy are different specifications. An instrument can resolve two species and…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #80 · Access › International · 5 Mar 2025 · 0 likes Adding the measurement that post #79 says would settle it. Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #51 · Sourcing › Red flags · 11 Feb 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
Protein density versus volume when you cannot eat much Replied, post #104 · Nutrition & Training › Protein & intake · 10 Feb 2025 · 0 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #33 · Evidence › Meta-analyses · 31 Jan 2025 · 16 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. It is a small point…
UK access routes, dated and sourced — a second dataset Replied, post #32 · Regional › UK & Ireland · 28 Jan 2025 · 0 likes Where a member reports a decision, the useful detail is the stated reason rather than the outcome, because the reason is what generalises. One more caveat and then I…
What we do not know about retatrutide, listed explicitly Replied, post #67 · Compounds › Retatrutide · 23 Jan 2025 · 3 likes Everything in post #63 holds. The case it does not cover is the one I have. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #44 · Compounds › Oral incretins · 12 Jan 2025 · 1 like The confident answers on Dose numbers for oral formulations and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #4 · Compounds › Repair & healing peptides · 5 Jan 2025 · 0 likes What would change my mind on BPC-157 is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #15 · Pharmacology › Receptor biology · 31 Dec 2024 · 0 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. One more thing on Biased agonism that took me far too long to see: the two figures…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #93 · Compounds › Semaglutide · 24 Dec 2024 · 12 likes I read post #89 twice before replying, because I had assumed the opposite. On the injection-day question: the labelling for licensed semaglutide allows the day to be…
Fixed versus detachable needles: the trade-offs Replied, post #69 · Devices › Syringes & needles · 24 Dec 2024 · 5 likes The arithmetic in post #67 is right; the assumption feeding it is the part to check. U-100 means the barrel is graduated for a solution containing one hundred units of…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #17 · Data & Tools › Calculators · 12 Dec 2024 · 24 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
Washout with a one-week half-life: the arithmetic Replied, post #77 · Research Methods › N-of-1 designs · 6 Dec 2024 · 0 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1. That…
Washout with a one-week half-life: the arithmetic Replied, post #28 · Research Methods › N-of-1 designs · 27 Nov 2024 · 7 likes Thank you for taking the time. That was more work than a reply usually is.
Reading a supplementary appendix and finding the interesting part Replied, post #31 · Evidence › Trials · 26 Nov 2024 · 0 likes Adding the measurement that post #30 says would settle it. The reason reading a supplementary appendix is hard to answer is that the obvious measurement and the…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #42 · Compounds › Tirzepatide · 18 Nov 2024 · 12 likes Post #40 is right about the mechanism and I think understates the practical bit. The five maintenance doses in the tirzepatide programme give a genuine dose-response…
Time to steady state after a dose increase Replied, post #95 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 23 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
Why I ask for the gradient before I discuss the number Replied, post #18 · Analytics › HPLC & UHPLC · 5 Sep 2024 · 0 likes If two laboratories disagree by more than two or three percentage points, work through method, integration, sample handling, whether it was the same lot and the same…
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #2 · Compounds › Retatrutide · 23 Aug 2024 · 28 likes Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is the one people find counter-intuitive. It raises energy expenditure…
High-resolution MS on aggregates and what it can see — one year on Replied, post #35 · Analytics › Mass spectrometry · 17 Aug 2024 · 19 likes The arithmetic in post #33 is right; the assumption feeding it is the part to check. Marking my uncertainty on High-resolution explicitly. I am confident about the…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #29 · Clinical › Prescriber conversations · 30 Jul 2024 · 11 likes If the answer is no, asking for the reason is reasonable and the reason is usually specific. It is also what makes an appeal possible where one exists. The interesting…
The mass-error checker and its intended scope Replied, post #153 · Data & Tools › Calculators · 25 Jul 2024 · 0 likes Offering a way to settle mass-error checker rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #83 · Compounds › Retatrutide · 22 Jul 2024 · 0 likes Where I would push back on the Retatrutide dose escalation consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
The mass-error checker and its intended scope Replied, post #117 · Data & Tools › Calculators · 12 Jul 2024 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #107 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes Post #105 and I disagree about the size of the effect, not about the direction. The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #12 · Practice › Dosing & titration · 6 Jul 2024 · 0 likes An honest declaration on Splitting a weekly dose: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding…
The mass-error checker and its intended scope Replied, post #92 · Data & Tools › Calculators · 2 Jul 2024 · 3 likes Answering the question post #88 raises rather than the one it answers. A note on scope: what I am saying about mass-error checker applies to the case in the first post…
Cold packs, phase-change material, and what survives ten days Replied, post #2 · Sourcing › Logistics · 8 Jun 2024 · 8 likes Adding a data point of agreement rather than a data point.